The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $22,160.00 firm fixed-price purchase order to the University of North Carolina at Chapel Hill (UNC-CH) to provide Collaborative Cross (CC) mice for tick-borne disease studies being conducted at Rocky Mountain Laboratories (RML). The award has an ultimate completion date of October 15, 2024 and does not utilize a set-aside designation.
This purchase order is issued under UNC-CH's existing $146.3 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with NIAID to provide pre-clinical research services, including the development and refinement of animal models, to support the agency's mission of advancing medical countermeasures against emerging infectious diseases and antimicrobial resistance.
Generated 8/9/24, 9:12 AM